Please do not leave this page until complete. This can take a few moments.
Marlborough pharmaceutical firm Sunovion is applying for U.S. Food and Drug Administration approval for a new drug to treat binge eating disorder.
The drug, called dasotraline, would treat adults with moderate to severe cases of the eating disorder, which Sunovion said is estimated to affect 4.1 million Americans and occur at rates three times higher than anorexia and bulimia combined.
Sunovion said Tuesday that the FDA has accepted the company's new drug application for review.
Clinical data for the drug showed that once-daily medication significantly reduced the number of binge days for adults with moderate-to-severe binge eating disorder, and was shown to be generally well-tolerated by patients. The test took place during two 12-week, randomized, placebo-controlled studies.
Binge eating disorder involves frequently consuming unusually large amounts of food and feeling unable to stop eating. It is similar to bulimia, a condition when people also overeat but compensate by vomiting to avoid gaining weight.
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments